Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Naturally occurring UBIAD1 mutations differentially affect menaquinone biosynthesis and vitamin K-dependent carboxylation. | FEBS J | 2022 | 34813684 | PubTator, text mining | PubMed |
| Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy. | Med Chem Res | 2022 | 34803342 | PubTator, text mining | PubMed |
| Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. | Biomed Pharmacother | 2022 | 34801852 | PubTator, text mining | PubMed |
| Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer. | Mol Carcinog | 2022 | 34559922 | PubTator, text mining | PubMed |
| Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs. | Endocr Rev | 2022 | 34520530 | PubTator, text mining | PubMed |
| Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood. | Ann Rheum Dis | 2022 | 34462261 | PubTator, text mining | PubMed |
| Phase separation in immune signalling. | Nat Rev Immunol | 2022 | 34230650 | PubTator, text mining | PubMed |
| Phosphoregulation of the autophagy machinery by kinases and phosphatases. | Autophagy | 2022 | 33970777 | PubTator, text mining | PubMed |
| Critical DNA damaging pathways in tumorigenesis. | Semin Cancer Biol | 2022 | 33905873 | PubTator, text mining | PubMed |
| Integrative Proteomic Analysis of Multiple Posttranslational Modifications in Inflammatory Response. | Genomics Proteomics Bioinformatics | 2022 | 33662623 | PubTator, text mining | PubMed |
| A Progressive Loss of phosphoSer138-Profilin Aligns with Symptomatic Course in the R6/2 Mouse Model of Huntington's Disease: Possible Sex-Dependent Signaling. | Cell Mol Neurobiol | 2022 | 33108594 | PubTator, text mining | PubMed |
| Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics. | RSC Adv | 2021 | 35492478 | PubTator, text mining | PubMed |
| Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance. | Front Physiol | 2021 | 35264975 | PubTator, text mining | PubMed |
Cluster analyses of the TCGA and a TMA dataset using the coexpression of HSP27 and CRYAB improves alignment with clinical-pathological parameters of breast cancer and suggests different epichaperome influences for each sHSP. | Cell Stress Chaperones | 2021 | 35235182 | PubTator, text mining | PubMed |
| Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity. | Nat Cancer | 2021 | 35121890 | PubTator, text mining | PubMed |
| Shaping the Innate Immune Response Through Post-Transcriptional Regulation of Gene Expression Mediated by RNA-Binding Proteins. | Front Immunol | 2021 | 35087521 | PubTator, text mining | PubMed |
| Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections. | Front Cell Infect Microbiol | 2021 | 35083168 | PubTator, text mining | PubMed |
| Molecular Events Involved in Influenza A Virus-Induced Cell Death. | Front Microbiol | 2021 | 35069499 | PubTator, text mining | PubMed |
| RNA Granules in Antiviral Innate Immunity: A Kaposi's Sarcoma-Associated Herpesvirus Journey. | Front Microbiol | 2021 | 35069491 | PubTator, text mining | PubMed |
| Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. | Cell Rep Med | 2021 | 35028612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=35